MYBA_HUMAN - dbPTM
MYBA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MYBA_HUMAN
UniProt AC P10243
Protein Name Myb-related protein A {ECO:0000303|PubMed:7987850, ECO:0000303|PubMed:8058310}
Gene Name MYBL1
Organism Homo sapiens (Human).
Sequence Length 752
Subcellular Localization Nucleus .
Protein Description Transcription factor that specifically recognizes the sequence 5'-YAAC[GT]G-3'. [PubMed: 8058310]
Protein Sequence MAKRSRSEDEDDDLQYADHDYEVPQQKGLKKLWNRVKWTRDEDDKLKKLVEQHGTDDWTLIASHLQNRSDFQCQHRWQKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWSLIAKHLKGRIGKQCRERWHNHLNPEVKKSSWTEEEDRIIYEAHKRLGNRWAEIAKLLPGRTDNSIKNHWNSTMRRKVEQEGYLQDGIKSERSSSKLQHKPCAAMDHMQTQNQFYIPVQIPGYQYVSPEGNCIEHVQPTSAFIQQPFIDEDPDKEKKIKELEMLLMSAENEVRRKRIPSQPGSFSSWSGSFLMDDNMSNTLNSLDEHTSEFYSMDENQPVSAQQNSPTKFLAVEANAVLSSLQTIPEFAETLELIESDPVAWSDVTSFDISDAAASPIKSTPVKLMRIQHNEGAMECQFNVSLVLEGKKNTCNGGNSEAVPLTSPNIAKFSTPPAILRKKRKMRVGHSPGSELRDGSLNDGGNMALKHTPLKTLPFSPSQFFNTCPGNEQLNIENPSFTSTPICGQKALITTPLHKETTPKDQKENVGFRTPTIRRSILGTTPRTPTPFKNALAAQEKKYGPLKIVSQPLAFLEEDIREVLKEETGTDLFLKEEDEPAYKSCKQENTASGKKVRKSLVLDNWEKEESGTQLLTEDISDMQSENRFTTSLLMIPLLEIHDNRCNLIPEKQDINSTNKTYTLTKKKPNPNTSKVVKLEKNLQSNCEWETVVYGKTEDQLIMTEQARRYLSTYTATSSTSRALIL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MAKRSRSEDEDD
---CCCCCCCCCCCC
39.1825159151
7Phosphorylation-MAKRSRSEDEDDDL
-CCCCCCCCCCCCCC
51.1225159151
16PhosphorylationDEDDDLQYADHDYEV
CCCCCCCCCCCCCCC
22.6928985074
21PhosphorylationLQYADHDYEVPQQKG
CCCCCCCCCCCHHHC
18.5327642862
79UbiquitinationQCQHRWQKVLNPELI
CCHHHHHHHHCHHHH
41.5521890473
79UbiquitinationQCQHRWQKVLNPELI
CCHHHHHHHHCHHHH
41.5521890473
87UbiquitinationVLNPELIKGPWTKEE
HHCHHHHCCCCCHHH
72.11-
92UbiquitinationLIKGPWTKEEDQRVI
HHCCCCCHHHHHHHH
56.06-
104UbiquitinationRVIELVQKYGPKRWS
HHHHHHHHHCHHHHH
44.7021890473
104UbiquitinationRVIELVQKYGPKRWS
HHHHHHHHHCHHHHH
44.7021890473
108UbiquitinationLVQKYGPKRWSLIAK
HHHHHCHHHHHHHHH
63.24-
138SumoylationNHLNPEVKKSSWTEE
HHCCHHHHHCCCCHH
45.32-
138UbiquitinationNHLNPEVKKSSWTEE
HHCCHHHHHCCCCHH
45.32-
138SumoylationNHLNPEVKKSSWTEE
HHCCHHHHHCCCCHH
45.32-
166UbiquitinationNRWAEIAKLLPGRTD
CHHHHHHHHCCCCCC
57.10-
199SumoylationGYLQDGIKSERSSSK
CCCHHCCCCCCCCCC
52.3628112733
199UbiquitinationGYLQDGIKSERSSSK
CCCHHCCCCCCCCCC
52.36-
394AcetylationPIKSTPVKLMRIQHN
CCCCCCEEEEEEECC
37.4619608861
418AcetylationVSLVLEGKKNTCNGG
EEEEEECCCCCCCCC
33.2125953088
433PhosphorylationNSEAVPLTSPNIAKF
CCCCCCCCCCCHHHC
35.7525627689
434PhosphorylationSEAVPLTSPNIAKFS
CCCCCCCCCCHHHCC
24.5125850435
441PhosphorylationSPNIAKFSTPPAILR
CCCHHHCCCCHHHHH
39.0222210691
442PhosphorylationPNIAKFSTPPAILRK
CCHHHCCCCHHHHHH
36.1027050516
458PhosphorylationRKMRVGHSPGSELRD
CCCCCCCCCCCCCCC
25.6530266825
461PhosphorylationRVGHSPGSELRDGSL
CCCCCCCCCCCCCCC
36.5227732954
477AcetylationDGGNMALKHTPLKTL
CCCCCCCCCCCCCCC
35.5725953088
479PhosphorylationGNMALKHTPLKTLPF
CCCCCCCCCCCCCCC
28.8227251275
521PhosphorylationCGQKALITTPLHKET
CCCEEEEECCCCCCC
24.1830266825
522PhosphorylationGQKALITTPLHKETT
CCEEEEECCCCCCCC
19.5030266825
541PhosphorylationKENVGFRTPTIRRSI
HCCCCCCCHHHHHHH
23.6323312004
543PhosphorylationNVGFRTPTIRRSILG
CCCCCCHHHHHHHCC
26.8823312004
547PhosphorylationRTPTIRRSILGTTPR
CCHHHHHHHCCCCCC
16.5922199227
551PhosphorylationIRRSILGTTPRTPTP
HHHHHCCCCCCCCCC
30.1322199227
552PhosphorylationRRSILGTTPRTPTPF
HHHHCCCCCCCCCCC
14.6922199227
555PhosphorylationILGTTPRTPTPFKNA
HCCCCCCCCCCCCHH
32.4922199227
557PhosphorylationGTTPRTPTPFKNALA
CCCCCCCCCCCHHHH
40.529417069
560AcetylationPRTPTPFKNALAAQE
CCCCCCCCHHHHHHH
42.3825953088
592SumoylationEDIREVLKEETGTDL
HHHHHHHHHHHCCCC
59.6928112733
602SumoylationTGTDLFLKEEDEPAY
HCCCCEECCCCCHHH
52.2928112733
602SumoylationTGTDLFLKEEDEPAY
HCCCCEECCCCCHHH
52.29-
617PhosphorylationKSCKQENTASGKKVR
HHHCCCCCCCCCCCH
22.8128555341
619PhosphorylationCKQENTASGKKVRKS
HCCCCCCCCCCCHHH
49.4528555341
621AcetylationQENTASGKKVRKSLV
CCCCCCCCCCHHHHH
45.6730586621
626PhosphorylationSGKKVRKSLVLDNWE
CCCCCHHHHHHCCCC
17.1022199227
643PhosphorylationESGTQLLTEDISDMQ
CHHCEEEECCHHHHH
39.9624043423
647PhosphorylationQLLTEDISDMQSENR
EEEECCHHHHHCCCC
39.0824043423
651PhosphorylationEDISDMQSENRFTTS
CCHHHHHCCCCCCCH
30.1524043423
678AcetylationRCNLIPEKQDINSTN
CCCCCCCCCCCCCCC
48.1726051181
683PhosphorylationPEKQDINSTNKTYTL
CCCCCCCCCCCEEEE
33.4229978859
684PhosphorylationEKQDINSTNKTYTLT
CCCCCCCCCCEEEEE
35.9229978859
686UbiquitinationQDINSTNKTYTLTKK
CCCCCCCCEEEEEEC
42.89-
687PhosphorylationDINSTNKTYTLTKKK
CCCCCCCEEEEEECC
24.6529978859
688PhosphorylationINSTNKTYTLTKKKP
CCCCCCEEEEEECCC
11.0229978859
689PhosphorylationNSTNKTYTLTKKKPN
CCCCCEEEEEECCCC
32.9329978859
691PhosphorylationTNKTYTLTKKKPNPN
CCCEEEEEECCCCCC
32.7729978859
704AcetylationPNTSKVVKLEKNLQS
CCHHHHEEEHHHHHH
54.6520167786
743PhosphorylationYLSTYTATSSTSRAL
HHHHHCCCCCCCCEE
18.5328555341
745PhosphorylationSTYTATSSTSRALIL
HHHCCCCCCCCEECC
26.5068696077

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
7SPhosphorylationKinaseCSNK2A1P68400
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MYBA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MYBA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NUCL_HUMANNCLphysical
10660576
LIN9_HUMANLIN9physical
28514442
LIN52_HUMANLIN52physical
28514442
LIN54_HUMANLIN54physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MYBA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-394, AND MASS SPECTROMETRY.

TOP